StrainScan Pro Demonstrates Versatility as MDCE Applies Core AI Vision Technology Across Regulated Retail and Large-Scale Agriculture (OTCID:MDCE)

Rhea-AI Summary

Medical Care Technologies (OTCID:MDCE) highlighted the cross-industry versatility of its StrainScan Pro AI vision platform, which uses a single computer-vision architecture for both regulated retail environments and large-scale agriculture. The software supports visual quality verification for licensed retailers and agricultural tasks such as early pest, crop-stress, and quality detection.

According to Medical Care Technologies, StrainScan Pro is optimized for deployment on iPad Air devices, giving both sectors a uniform, portable enterprise solution while allowing the company to advance one proprietary system. The company develops and commercializes AI vision software and does not handle cultivation or sale of plant products.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Proprietary Platform Highlights the Strength of a Single AI Vision System Serving Multiple Trillion Dollar Industries

MESA, AZ / ACCESS Newswire / August 26, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today emphasized the cross-industry versatility of its StrainScan Pro platform, underscoring how a single proprietary AI vision system is being applied across both regulated retail environments and large-scale agricultural operations.

StrainScan Pro is designed to deliver consistent visual analysis capabilities that support quality verification for licensed retail operators while also addressing agricultural needs such as early detection of pests, crop stress, and quality indicators. By leveraging the same core computer-vision architecture across these distinct sectors, the platform demonstrates the flexibility of Medical Care Technologies' AI vision approach.

The software remains optimized for deployment on iPad Air devices, allowing operators in both retail and agricultural settings to utilize a uniform, portable enterprise solution. This shared foundation enables the Company to advance one proprietary system rather than developing fragmented tools for each vertical.

"The true strength of StrainScan Pro lies in its ability to serve more than one industry with the same underlying technology," said Marshall Perkins, CEO of Medical Care Technologies. "Whether supporting visual quality verification in regulated retail or assisting with crop and field-level analysis in agriculture, we are focused on delivering a versatile AI vision platform that creates value across multiple large-scale markets."

Medical Care Technologies is a technology company. It develops and commercializes AI vision software and does not cultivate, process, distribute, or sell cannabis or any plant products.

By applying its core technology across multi-billion-dollar retail sectors and the multi-trillion-dollar global agriculture market, Medical Care Technologies continues to position StrainScan Pro as a flexible enterprise platform with broad commercial relevance.

Investors and industry participants can explore the platform at:
https://strainscanpro.com

Medical Care Technologies continues to advance its AI vision capabilities across high-value verticals while generating revenue through its operating subsidiaries.

About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. Visit: https://medicalcaretechnologies.com

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.

Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: marshall@medicalcaretechnologies.com
Websites: https://medicalcaretechnologies.com | https://strainscanpro.com

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

FAQ

What is StrainScan Pro from Medical Care Technologies (OTCID:MDCE)?

StrainScan Pro is an AI vision platform designed for visual quality analysis in regulated retail and large-scale agriculture. According to Medical Care Technologies, it uses a single computer-vision architecture to support tasks like quality verification, early pest detection, and crop-stress monitoring across multiple enterprise environments.

How does StrainScan Pro (MDCE) use AI vision in agriculture and retail?

StrainScan Pro applies one AI computer-vision system to both sectors, analyzing visual data for quality and early issues. According to Medical Care Technologies, it helps licensed retailers verify product visuals and assists agriculture operators with detecting pests, crop stress, and other field-level quality indicators.

Which devices support StrainScan Pro from Medical Care Technologies (OTCID:MDCE)?

StrainScan Pro is optimized for deployment on iPad Air devices, according to Medical Care Technologies. This focus allows operators in both regulated retail and agricultural settings to use a uniform, portable enterprise solution while the company concentrates development on a single proprietary AI vision platform.

Does Medical Care Technologies (MDCE) cultivate or sell cannabis products?

Medical Care Technologies states it does not cultivate, process, distribute, or sell cannabis or any plant products. According to the company, its business is focused on developing and commercializing AI vision software that can be applied across regulated retail sectors and the global agriculture market.

How is Medical Care Technologies (OTCID:MDCE) positioning StrainScan Pro in the market?

Medical Care Technologies is positioning StrainScan Pro as a flexible enterprise AI vision platform serving regulated retail and large-scale agriculture. According to the company, applying one proprietary system across multi-billion-dollar retail sectors and the multi-trillion-dollar global agriculture market supports broad commercial relevance and ongoing revenue generation.

Where can investors learn more about StrainScan Pro and MDCE?

Investors can review StrainScan Pro at https://strainscanpro.com and learn about Medical Care Technologies at https://medicalcaretechnologies.com. According to the company, these sites provide details on its AI vision platform, broader AI-powered applications, and its focus on high-value enterprise verticals.